JNJ
Price
$156.01
Change
+$0.45 (+0.29%)
Updated
Jul 3 closing price
Capitalization
380.22B
9 days until earnings call
RHHBY
Price
$40.44
Change
-$0.71 (-1.73%)
Updated
Jul 3 closing price
Capitalization
250.69B
18 days until earnings call
Interact to see
Advertisement

JNJ vs RHHBY

Header iconJNJ vs RHHBY Comparison
Open Charts JNJ vs RHHBYBanner chart's image
Johnson & Johnson
Price$156.01
Change+$0.45 (+0.29%)
Volume$3.48M
Capitalization380.22B
Roche Holding
Price$40.44
Change-$0.71 (-1.73%)
Volume$624.51K
Capitalization250.69B
JNJ vs RHHBY Comparison Chart in %
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. RHHBY commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and RHHBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (JNJ: $156.01 vs. RHHBY: $40.44)
Brand notoriety: JNJ: Notable vs. RHHBY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 44% vs. RHHBY: 38%
Market capitalization -- JNJ: $380.22B vs. RHHBY: $250.69B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 2 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than RHHBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 6 TA indicator(s) are bullish while RHHBY’s TA Score has 5 bullish TA indicator(s).

  • JNJ’s TA Score: 6 bullish, 4 bearish.
  • RHHBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than RHHBY.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +2.63% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

JNJ is expected to report earnings on Jul 16, 2025.

RHHBY is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than RHHBY($251B). JNJ has higher P/E ratio than RHHBY: JNJ (30.34) vs RHHBY (19.46). RHHBY YTD gains are higher at: 19.796 vs. JNJ (9.672). JNJ has higher annual earnings (EBITDA): 23.3B vs. RHHBY (19.1B). JNJ has more cash in the bank: 22.9B vs. RHHBY (7.51B). RHHBY has less debt than JNJ: RHHBY (25.4B) vs JNJ (29.3B). JNJ has higher revenues than RHHBY: JNJ (85.2B) vs RHHBY (60B).
JNJRHHBYJNJ / RHHBY
Capitalization380B251B151%
EBITDA23.3B19.1B122%
Gain YTD9.67219.79649%
P/E Ratio30.3419.46156%
Revenue85.2B60B142%
Total Cash22.9B7.51B305%
Total Debt29.3B25.4B115%
FUNDAMENTALS RATINGS
JNJ vs RHHBY: Fundamental Ratings
JNJ
RHHBY
OUTLOOK RATING
1..100
1864
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
4479
SMR RATING
1..100
3399
PRICE GROWTH RATING
1..100
3950
P/E GROWTH RATING
1..100
7917
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (15) in the null industry is in the same range as JNJ (18) in the Pharmaceuticals Major industry. This means that RHHBY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (44) in the Pharmaceuticals Major industry is somewhat better than the same rating for RHHBY (79) in the null industry. This means that JNJ’s stock grew somewhat faster than RHHBY’s over the last 12 months.

JNJ's SMR Rating (33) in the Pharmaceuticals Major industry is significantly better than the same rating for RHHBY (99) in the null industry. This means that JNJ’s stock grew significantly faster than RHHBY’s over the last 12 months.

JNJ's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as RHHBY (50) in the null industry. This means that JNJ’s stock grew similarly to RHHBY’s over the last 12 months.

RHHBY's P/E Growth Rating (17) in the null industry is somewhat better than the same rating for JNJ (79) in the Pharmaceuticals Major industry. This means that RHHBY’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJRHHBY
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
41%
Bearish Trend 4 days ago
43%
Momentum
ODDS (%)
Bullish Trend 4 days ago
41%
Bullish Trend 4 days ago
46%
MACD
ODDS (%)
Bullish Trend 4 days ago
41%
Bearish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
40%
Bearish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
39%
Bearish Trend 4 days ago
52%
Advances
ODDS (%)
Bullish Trend 7 days ago
40%
Bullish Trend 25 days ago
51%
Declines
ODDS (%)
Bearish Trend 17 days ago
43%
Bearish Trend 7 days ago
46%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
44%
Bearish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXLS45.270.62
+1.39%
ExlService Holdings
PRE8.000.09
+1.14%
Prenetics Global Limited
NLOP32.820.22
+0.67%
Net Lease Office Properties
ESRT8.320.04
+0.48%
Empire State Realty Trust
AGNCN25.300.04
+0.16%
AGNC Investment Corp

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with NVS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.29%
NVS - JNJ
56%
Loosely correlated
-1.54%
GSK - JNJ
52%
Loosely correlated
-0.86%
PFE - JNJ
51%
Loosely correlated
+0.24%
ABBV - JNJ
43%
Loosely correlated
-0.77%
AMGN - JNJ
43%
Loosely correlated
+0.47%
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-1.73%
RHHVF - RHHBY
66%
Loosely correlated
-2.91%
RHHBF - RHHBY
36%
Loosely correlated
N/A
ABBV - RHHBY
21%
Poorly correlated
-0.77%
JNJ - RHHBY
20%
Poorly correlated
+0.29%
CHGCY - RHHBY
20%
Poorly correlated
-0.89%
More